Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 2

Results: 13

In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 255, doi. 10.1038/onc.2012.547

By:

Casar, B;
Rimann, I;
Kato, H;
Shattil, S J;
Quigley, J P;
Deryugina, E I

Publication type:

Article

Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 225, doi. 10.1038/onc.2012.563

By:

Brouxhon, S M;
Kyrkanides, S;
Teng, X;
Athar, M;
Ghazizadeh, S;
Simon, M;
O'Banion, M K;
Ma, L

Publication type:

Article

hCINAP is a novel regulator of ribosomal protein-HDM2-p53 pathway by controlling NEDDylation of ribosomal protein S14.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 246, doi. 10.1038/onc.2012.560

By:

Zhang, J;
Bai, D;
Ma, X;
Guan, J;
Zheng, X

Publication type:

Article

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 148, doi. 10.1038/onc.2012.572

By:

Montero, J C;
Esparís-Ogando, A;
Re-Louhau, M F;
Seoane, S;
Abad, M;
Calero, R;
Ocaña, A;
Pandiella, A

Publication type:

Article

EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 173, doi. 10.1038/onc.2012.579

By:

Wu, J;
Patmore, D M;
Jousma, E;
Eaves, D W;
Breving, K;
Patel, A V;
Schwartz, E B;
Fuchs, J R;
Cripe, T P;
Stemmer-Rachamimov, A O;
Ratner, N

Publication type:

Article

Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 193, doi. 10.1038/onc.2012.569

By:

Yang, Q;
Jie, Z;
Ye, S;
Li, Z;
Han, Z;
Wu, J;
Yang, C;
Jiang, Y

Publication type:

Article

Role of OGR1 in myeloid-derived cells in prostate cancer.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 157, doi. 10.1038/onc.2012.566

By:

Yan, L;
Singh, L S;
Zhang, L;
Xu, Y

Publication type:

Article

ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 212, doi. 10.1038/onc.2012.564

By:

Bergholz, J;
Zhang, Y;
Wu, J;
Meng, L;
Walsh, E M;
Rai, A;
Sherman, M Y;
Jim Xiao, Z-X

Publication type:

Article

WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 203, doi. 10.1038/onc.2012.565

By:

Teng, Y;
Mei, Y;
Hawthorn, L;
Cowell, J K

Publication type:

Article

Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 165, doi. 10.1038/onc.2012.583

By:

Kumari, U;
Ya Jun, W;
Huat Bay, B;
Lyakhovich, A

Publication type:

Article

The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 236, doi. 10.1038/onc.2012.562

By:

Todd, J R;
Scurr, L L;
Becker, T M;
Kefford, R F;
Rizos, H

Publication type:

Article

Roles of microRNAs during prostatic tumorigenesis and tumor progression.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 135, doi. 10.1038/onc.2013.54

By:

Fang, Y-X;
Gao, W-Q

Publication type:

Article

The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle.

Published in:

Oncogene, 2014, v. 33, n. 2, p. 181, doi. 10.1038/onc.2012.570

By:

Ichim, G;
Mola, M;
Finkbeiner, M G;
Cros, M-P;
Herceg, Z;
Hernandez-Vargas, H

Publication type:

Article